Objective: To compare the analytical performances of the enzymatic method (EM) and capillary electrophoresis (CE) for hemoglobin A1c (HbA 1c ) measurement.
glucose to the N-terminal valine of the β-chain of hemoglobin. 1 The American Diabetes Association (ADA) and World Studies have shown that other Hb variants (HbS, HbE, HbC, and HbD) do not interfere with HbA 1c measurement by CE and enzymatic methods (EMs), but HbF might be a significant source of interference error. 6, 7 CE and EMs correlate well with the HPLC method, 8, 9 but there are not many studies comparing EMs with CE.
The aim of this study was to perform verification of analytical specifications (precision, carryover, linearity, interferences, and stability) and method comparison for 2 different assays for HbA 1c measurement, namely, direct whole blood enzymatic assay (Abbott Laboratories, Inc) and CE (Sebia).
Materials and Methods

Study Design
Blood specimens used for this study were leftover patient specimens referred to the laboratory for routine HbA 1c testing. All blood specimens were collected in ethylenediaminetetraacetic acid (EDTA) tubes (Vacuette tripotassium (K 3 ) EDTA Tubes, 4 mL; Greiner Bio-One International GmbH).
The study was conducted from April 2015 through December 2016. First, we performed a comparison of 2 different assays for HbA 1c measurement. Precision, carryover, stability, linearity, and interferences were tested during the specified period for both methods. The precision study was performed following the Clinical Laboratory Standards Institute (CLSI) EP15-A2 guideline. 10 The results are expressed in IFCC units (mmol/mol) and DCCT/National Glycohemoglobin Standardization Program (NGSP) units (%) after conversion using the IFCC-NGSP master equation HbA 1c (%) = (0.09148 × IFCC) + 2.152. 8, 12, 13 Assay specifications are featured in Table S1 (available online-only).
Methods
CE: Minicap Flex Piercing Analyzer
Verification of Analytical Specifications of the Methods and Comparison Studies
Precision
For this purpose, patient blood specimens have been used for both methods and commercial quality controls for EM only. All specimens used for precision testing were analysed in triplicate, during a 5-day period. Carryover study for EM. We tested carryover for EM using 2 protocols, specifically evaluating analyte carryover between 2 whole blood specimens and whole blood and serum specimens. In the first protocol, 1 whole blood specimen with normal HbA 1c concentration was divided into 2 aliquots and analyzed before and after the specimen with the high HbA 1c concentration. The second protocol was designed because serum and whole blood specimens are tested on the same analyzers (Abbott Architect c8000) during routine laboratory work. In this protocol, 1 serum specimen was divided into 2 aliquots and analyzed before and after the whole blood specimen. To evaluate potential contamination with erythrocytes from the whole blood, in serum specimen potassium, magnesium, calcium, phosphorus, lactate dehydrogenase, aspartate aminotransferase (AST), total proteins, and glucose were measured on the Architect c8000 (with the original manufacturers reagents). Measurements were performed in triplicate, and average values were used for calculation. For all methods, carryover bias was calculated as follows:
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Acceptance criterion for HbA 1c carryover was set at 3% and for all other analytes, desirable specification for bias was taken from Ricos et al 15 ; these data are listed in Table S2 (available online-only).
Stability
Stability was evaluated by measuring HbA 1c concentration in the same specimen during 12 consecutive days for EM and 14 days for CE. Specimens were stored in the refrigerator (2°-8°C) between measurements. For each day, concentration of HbA 1c was compared with the concentration obtained on the first day of measurement by calculating bias (%). Three specimens with different HbA1c concentrations were used for both methods. A criterion for stability bias was set at 3% or less. 15 
Method Comparison
Comparison of these 2 methods was conducted during an 8-day period using 93 patient specimens. These specimens were analyzed by EM, stored in the refrigerator (2°-8°C) for a maximum of 3 days, and then analyzed by CE.
Linearity
The linearity was evaluated by measuring 
Interferences
Both methods were tested for the interference of lipemia using Intralipid 20% emulsion for infusion (Fresenius Kabi AG). Intralipid was added in increased concentration into the whole blood specimen, and the bias of measured HbA1c was calculated for each one. 16, 17 We evaluated the interference of HbF according to a protocol in which whole blood specimens were spiked with an increasing volume of pooled fresh whole blood from a neonate (left over from routine complete blood count 19, 20 HbA 1c in all 3 pools for labile HbA 1c and cHb interference was measured via EM and CE, before and after incubation, and interferents and biases were calculated. All measurements were made in duplicate. For all interferences studies, a criterion for acceptable bias was set at 6% or less. 21 
Statistical Analysis
For comparison of 2 methods, results were analyzed by the Bland-Altman plot. 22 The difference between methods is presented on the y axis for evaluation of constant difference; the average of both methods is presented on the x axis. Statistical analysis was performed using MedCalc software, version 11.5.1.0 (MedCalc Software).
Results
Precision Study
Obtained repeatability and intralaboratory precision data are summarized in Table S3 (available online-only). All coefficients of variation were within acceptance criteria for both methods (<3% for IFCC units, <2% for NGSP units).
Carryover Study
Carryover testing between high and low HbA 1c concentrations in whole blood specimens obtained acceptable mean biases for EM (0.27%) and CE (−1.0%). Also, in testing of carryover of whole blood to serum, all bias values were within acceptable criteria (Table S2 , available online-only).
Stability Study
For EM, biases were within the acceptance criteria for all specimens ( Figure S1 , available online-only). In the case of CE, biases were acceptable for the specimens with medium and high HbA 1c concentration but not for specimen with low HbA 1c concentration (32 mmol/mol [5.1%]), with obtained bias as high as 9.38% on the ninth day ( Figure S2 , available online-only).
Method Comparison Study
Bland-Altman analysis for comparison of EM and CE revealed significant constant (mean, 1.1 mmol/mol [0.11%]) ( Figure 1 and Figure S3 [available online-only]) and proportional (mean, 2.3% [for NGSP units, 1.6%]) differences (data not shown). Limits of agreement (±1.96 SD of differences) ranged from −1.9 to 4.0 mmol/mol (−0.2% to 0.4%) for constant difference ( Figure 1 and Figure S3 [available online-only]) and −4.0 to 8.6% (NGSP, −2.6% to 5.8%) for proportional difference (data not shown), respectively. EM underestimates the HbA 1c value, compared with CE. 
Linearity of the Methods
Interferences
The results of a study of lipemia interference showed that triglyceride levels as high as 42.37 mmol per L have no impact on the HbA 1c determination by CE (bias, <3.0%). For EM, the acceptable bias for triglyceride levels as high as 8.11 mmol per L has been obtained; however, increasing triglyceride concentration afterward causes a steep decrease of HbA 1c ( Figure 2 ). Based on intra-and interindividual biologic variation, intralaboratory CV of less than 3% (<2% for NGSP units) is recommended. 15, 23, 24 This recommendation was supported by the mathematical minimal ability to differentiate the upper normal concentration of 42 mmol/mol (6.0%) and diagnostic criterion of 48 mmol/mol (6.5%). 23 In our study, both methods achieved the criterion for intralaboratory imprecision, with an even more stringent goal of less than 2%
Figure 3
Interference of HbF (%) on hemoglobin (Hb)A1c measurement via the enzymatic method and capillary electrophoresis method.
Interference is presented with mean bias (%) for EM and bias (%) from single measurement for CE. Biases for both IFCC and NGSP units are presented.
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(recommended for NGSP units) achieved for medium and high HbA 1c concentrations expressed in IFCC units. This finding is important because it encompasses diagnostic and therapeutic targets.
In comparison with the findings of the first published evaluation of the Sebia machine as a new analyzer for HbA 1c assay by CE, the results of our study showed lower coefficients of variation. The reason for this finding may be the difference between the analyzers used. Whereas the CAPILLARYS 2 Flex piercing analyzer, which was used in the initial study, uses 8 capillaries, the Minicap-Flex piercing analyzer uses only 2 capillaries, thus lowering the impact of each capillary on overall imprecision. 8 Performing analysis of serum/plasma and whole blood specimens on the same analyzers might represent a risk due to potential contamination and/or carryover. Although analyzers include additional washing cycles in their protocols, one might be concerned that serum specimens analyzed after full-blood specimens might be falsely hemolyzed, due to the carryover of erythrocytes. Therefore, one of the strengths of our study is the comprehensive investigation of carryover effect on biochemistry analyzer, including analytes that are most vulnerable to the hemolysis effect. Both methods proved to be reliable, considering carryover effect between the whole blood specimens. Also, carryover effect obtained between whole blood and serum specimens was far below the desirable specifications for bias used as acceptance criteria. 15 Stability studies for CE and EM at the clinically relevant concentration of HbA 1c , showed overall bias lower than 2% during the entire tested period (12 days and 14 days, respectively). EM showed better overall stability; however, we were surprised to find high deviation (9.8%) for CE at a low HbA 1c concentration (32 mmol/mol [5.1%] The results of our study have shown that HbA 1c measurement by CE is influenced by the presence of HbF at a lower proportion (10.6%) than that declared by the manufacturer (15%). Our data are in concordance with those reported in a recent study in which significant interference was observed for HbA 1c measurement via the CAPILLARYS 2 FP analyzer for specimens with 10% to 15% HbF (relative bias, >±7%).
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Hemoglobin F has a lower glycation rate than HbA because approximately 60% of glycation of HbA occurs at the amino terminus of the β chain, and HbF has γ in place of β chains. 28 Because HbF migrates close to HbA0, separation of fractions is not efficient enough if one overestimates the HbA0 proportion, which artificially lowers the HbA 1c level. However, the presence of an increased level of HbF is obvious from an interfering peak in the chromatogram and therefore, misinterpretation of HbA 1c concentration can be safely avoided.
The results of our study indicate an insignificant influence of HbF levels as high as 55% on HbA 1c measurement with EM, which is much higher than the result of the recent study in which the bias for the same method is within 6% In our study, the interference of hemoglobin variants on HbA 1c measurement was limited to HbF only because based on the only available data on the frequency of hemoglobinopathic manifestations in Croatia, other variants in hemoglobin are rare (0.8%). 32 Therefore, we believe that the results of our study are applicable to our population.
A limitation to this study might be that we did not investigate the influence of acetylated HbA 1c . Also, other interferences listed in the manufacturer declarations for the CE method have not been investigated (bilirubin, urea, ascorbic acid, rheumatoid factor, glibenclamide). However, we believe that our study results still provide valuable data on potential interferences in HbA 1c testing.
In conclusion, the analytical performances of HbA 1c , as tested via EM and CE, are comparable, and both methods satisfy highly stringent analytical performance requirements; however, certain interferences can influence the measurements of each method. EM has the advantage of increased capacity and suitability for general chemistry analyzers. In contrast, CE has the important advantage of its ability to detect biological interference from hemoglobin variants that would affect the erythrocyte life span and lead to clinically misinterpreted HbA 1c results. LM
